AG0302-COVID19

· AnGes, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AG0302-COVID19, covering 2021-10-04 to 2022-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) [Phase 2, Phase 3]